{"id":"W3215974396","doi":"10.1093/neuonc/noab196.615","title":"NCOG-24. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Demographics; Chemotherapy; Internal medicine; Glioblastoma; Oncology; Proportional hazards model; Retrospective cohort study; Overall survival; Surgery","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000998831,0.0003266456,0.0005693677,0.00190728,0.0007300868,0.001166326,0.000948643,0.0003302289,0.002523787],"category_scores_gemma":[0.004253432,0.0002447519,0.0003661854,0.005061064,0.0003304197,0.0003139638,0.0006962346,0.0003820984,0.00063681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008217454,"about_ca_system_score_gemma":0.006508591,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7796849,"about_ca_topic_score_gemma":0.8341436,"domain_scores_codex":[0.9990665,0.0001823675,0.0001321632,0.0001725351,0.0002410954,0.0002053487],"domain_scores_gemma":[0.994909,0.0004699596,0.001939287,0.0002011554,0.001632057,0.0008484974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007615394,0.00004742408,0.9872075,0.0001146822,0.000125613,0.00007259078,0.0000917161,0.0002956005,0.0001128288,0.00003724691,0.004467263,0.006665998],"study_design_scores_gemma":[0.00006155643,0.00006668486,0.9966625,0.00004920984,0.00005982532,0.0001045631,0.0001843173,0.0005367356,0.00005875492,0.00002202482,0.002183003,0.0000108478],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9431663,0.001085704,0.0001518724,0.0002971515,0.00001858732,0.0001721867,0.05141167,0.00006545843,0.003631047],"genre_scores_gemma":[0.9665607,0.0003742265,0.0003748648,0.000165521,0.00001335595,0.0002186938,0.03096967,0.00002799006,0.001294967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2203151,"threshold_uncertainty_score":0.4432251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01932545421208712,"score_gpt":0.3094688731137458,"score_spread":0.2901434189016586,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}